Gallium dimercaptosuccinate as a novel tumor imaging agent
US5639439A · kind A · utility
1Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1994 |
| Grant date | Jun 17, 1997 |
| Priority date | — |
| Expiry date | Dec 15, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel tumor imaging agents in which the dimercaptosuccinic acid was dissolved in phosphate buffer and labelled with radioisotope gallium. The product of gallium dimercaptosuccinate has been characterized by a variety of experiments including serum stability, biodistribution and imaging experiment. As the results, the compound of gallium dimercaptosuccinate has been confirmed as a novel radiopharmaceutical for tumor imaging agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.